Related Experiment Video
Updated: Jul 4, 2025

Surgery and Behavioral Testing in the Tibial Neuroma Transposition Model in Rats
Published on: January 6, 2023
Surgery for benign nail tumor.
André Lencastre1, Charlotte Arnal2, Bertrand Richert2
1Serviço de Dermatologia, Hospital da Luz, Lisboa, Portugal.
Nail apparatus tumors differ from skin tumors in presentation and behavior. Benign tumors preserve nail structure, while malignant ones are destructive, requiring surgery to prevent dystrophy.
Area of Science:
- Dermatology
- Oncology
- Surgical Pathology
Background:
- Nail apparatus tumors exhibit distinct clinical behaviors compared to cutaneous counterparts.
- Certain tumors, like onychomatricoma, are exclusive to the nail apparatus.
- Superficial acral fibromyxoma shows a specific predilection for the nail apparatus.
Purpose of the Study:
- To differentiate the clinical presentation and behavior of nail apparatus tumors from skin tumors.
- To highlight unique nail apparatus tumors and those with specific tropism.
- To emphasize the importance of surgical treatment and anatomical knowledge for preventing nail dystrophy.
Main Methods:
- Clinical observation and comparison of nail apparatus tumors versus skin tumors.
- Histopathological analysis to characterize tumor types and their architectural impact.
- Review of surgical management principles for nail apparatus lesions.
Main Results:
- Nail tumors present and behave differently than skin tumors.
- Benign tumors generally maintain the nail apparatus architecture.
- Malignant tumors are characterized by destructive growth patterns.
Conclusions:
- Surgical intervention is the standard treatment for nail apparatus tumors.
- Thorough understanding of nail anatomy and surgical techniques is crucial.
- Adequate surgical management prevents postoperative nail dystrophy.
More Related Videos
07:41An Intramedullary Locking Nail for Standardized Fixation of Femur Osteotomies to Analyze Normal and Defective Bone Healing in Mice
Published on: November 13, 2016
07:58Stromal Vascular Fraction-enriched Fat Grafting for the Treatment of Symptomatic End-neuromata
Published on: November 23, 2017